Cardiovascular
-
23 May 2013
European cardiologists recognize contribution of medical device industry to improving patient care
read moreThe European cardiovascular medical device industry was presented on 20 May at the annual meeting of the European Association for Percutaneous Cardiovascular Interventions with the Ethica Award for its contribution to improving European patient care. Interventional cardiologists use narrow tubes, or catheters, passed through arteries or veins to reach the heart or other organs to carry out procedures and insert devices to treat disease. The award recognizes the role played by safe, innovative cardiovascular devices in addressing unmet medical needs and improving patient survival rates and quality of life.
-
Brussels, 10 May 2011
Overcoming barriers to eHealth
read moreToday, coinciding with the European Ministerial eHealth Conference in Budapest, Eucomed, the European medical technology industry association, has launched its position paper on eHealth describing the industry perspective including seven criteria that play a critical role in enabling the transformation of healthcare systems across Europe.
-
25 February 2011
European Commission objects to FDA remarks in a letter
25 February 2011 - According to Reuters: “A transatlantic spat has erupted after a top U.S. official suggested European patients may be "guinea pigs" for medical devices with less government oversight. A senior official at the European Commission, in a letter obtained by Reuters, complained to the U.S. Food and Drug Administration this month about comments from the FDA's device chief, Dr. Jeffrey Shuren.....” For the full story please go to the Reuters websiteread more -
Brussels, 08 June 2010
World Heart Rhythm Week: Eucomed joins Arrhythmia Alliance in raising awareness of heart rhythm disorders globally
Eucomed, the Medical Technology Industry Association, supports the World Heart Rhythm Week, a global event bringing together individuals and organisations to raise awareness about the impact of arrhythmias. This year’s campaign is themed, “Know Your Pulse”, and aims at promoting a better understanding of arrhythmic conditions and ensuring that preventive procedures such as pulse checks become routine.read more -
Brussels, 03 September 2009
Landmark trial concludes that Cardiac-Resynchronization Therapy (CRT) combined with Implantable cardioverter–defibrillator (ICD) reduces the risk of mortality and heart failures
read morePatients with cardiovascular disease have an increased risk of heart failure and death. In such patients an implantable cardioverter defibrillator (ICD) can often improve survival rates. Selected patients could benefit from a combination of an ICD and cardiac resynchronisation therapy (CRT-D), thus a clinical trial was designed to determine if combined ICD – CRT-D treatment reduces the risk of mortality and heart failure (HF) events.